Michael Schultz
Overview
Explore the profile of Michael Schultz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
183
Citations
2865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sarrami N, Nelson B, Leier S, Wilson J, Chan C, Meens J, et al.
EJNMMI Radiopharm Chem
. 2024 Nov;
9(1):79.
PMID: 39589608
Background: The objective of this research was the development and evaluation of Pb-labelled panitumumab (Pb-PSC-panitumumab) as an immuno-SPECT radioligand for the detection of EGFR + head and neck squamous cell...
2.
Lee S, Bushra M, Qiu L, Shao J, Olivera P, Leibovitzh H, et al.
Gastroenterology
. 2024 Oct;
168(2):385-388.e3.
PMID: 39384162
No abstract available.
3.
Khan A, Tarr A, Berahmana A, Johnson E, Schultz M, Johnson S
Gastroenterol Hepatol Bed Bench
. 2024 Sep;
17(3):260-269.
PMID: 39308536
Aim: We assessed the feasibility of point-of-care testing to gain insights into participants' knowledge, experience and its effect on hepatitis C management. Background: In New Zealand, only 50% of people...
4.
Gur-Arieh S, Eisenmann S, Henry A, Lucas M, Lenz D, Paxinos P, et al.
Archaeol Anthropol Sci
. 2024 Jul;
16(8):127.
PMID: 39072255
Supplementary Information: The online version contains supplementary material available at 10.1007/s12520-024-02000-w.
5.
Amiesimaka O, Allemann S, Braund R, Schultz M, Aluzaite K
Br J Clin Pharmacol
. 2024 Apr;
90(8):1911-1920.
PMID: 38689379
Aims: Inflammatory bowel disease (IBD) management entails long-term medication therapy. Worse disease outcomes and reduced quality of life might arise from poor medication adherence (MA). This study is the first...
6.
Amiesimaka O, Aluzaite K, Braund R, Schultz M
Patient Prefer Adherence
. 2024 Apr;
18:905-916.
PMID: 38660627
Inflammatory bowel disease (IBD) management is typified by a long-term medication regimen which can comprise multiple medications prescribed in different combinations, doses, frequencies, and with various administration routes. This complexity...
7.
Amiesimaka O, Aluzaite K, Braund R, Schultz M
N Z Med J
. 2024 Jan;
137(1588):25-36.
PMID: 38261772
Aims: Electronic health records (EHRs) are widely used in medication adherence (MA) assessment. Poor adherence in patients with inflammatory bowel diseases (IBD) can lead to worse disease outcomes and increased...
8.
Amiesimaka O, Aluzaite K, Braund R, Schultz M
Explor Res Clin Soc Pharm
. 2023 Dec;
12:100385.
PMID: 38146319
Background: A careful, often life-long, medication regimen is central to therapy for Inflammatory Bowel Disease (IBD) - a chronic gut disorder. Hence, medication adherence (MA) - patients taking medications in...
9.
Schultz M, Missbach-Guentner J, Wagner M, Tarasov P, Gresky J, Schmidt-Schultz T
Tuberculosis (Edinb)
. 2023 Nov;
143S:102370.
PMID: 38012919
The partial skeleton of a 22-24-year old female from Liushui, Southern Silk Road, Xinjiang (China) was analyzed using morphological and biochemical methods. The most striking finding in this individual of...
10.
Schultz M, Baziliansky S, Mitnik I, Ulitzur N, Campisi-Pinto S, Givoli S, et al.
Palliat Support Care
. 2023 Aug;
22(2):306-313.
PMID: 37605972
Objectives: Within the multidisciplinary team, there can sometimes be lack of clarity as to the specific different contributions of each of the psycho-social-spiritual professionals: social workers, psychologist, and spiritual caregivers....